| Literature DB >> 25297633 |
Gregory N Gan1, Justin Eagles2, Stephen B Keysar2, Guoliang Wang2, Magdalena J Glogowska2, Cem Altunbas1, Ryan T Anderson2, Phuong N Le2, J Jason Morton2, Barbara Frederick1, David Raben1, Xiao-Jing Wang3, Antonio Jimeno4.
Abstract
Local control and overall survival in patients with advanced head and neck squamous cell cancer (HNSCC) remains dismal. Signaling through the Hedgehog (Hh) pathway is associated with epithelial-to-mesenchymal transition, and activation of the Hh effector transcription factor Gli1 is a poor prognostic factor in this disease setting. Here, we report that increased GLI1 expression in the leading edge of HNSCC tumors is further increased by irradiation, where it contributes to therapeutic inhibition. Hh pathway blockade with cyclopamine suppressed GLI1 activation and enhanced tumor sensitivity to radiotherapy. Furthermore, radiotherapy-induced GLI1 expression was mediated in part by the mTOR/S6K1 pathway. Stroma exposed to radiotherapy promoted rapid tumor repopulation, and this effect was suppressed by Hh inhibition. Our results demonstrate that Gli1 that is upregulated at the tumor-stroma intersection in HNSCC is elevated by radiotherapy, where it contributes to stromal-mediated resistance, and that Hh inhibitors offer a rational strategy to reverse this process to sensitize HNSCC to radiotherapy. ©2014 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25297633 PMCID: PMC4253591 DOI: 10.1158/0008-5472.CAN-14-1346
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701